Thyroid lobectomy for papillary thyroid cancer: Long-term follow-up study of 1,088 cases

Keyphrases

• Thyroid Lobectomy 100%
• Papillary Thyroid Cancer 100%
• Recurrence-free Survival 50%
• Extrathyroidal Invasion 50%
• Initial Surgery 40%
• Lymph Node Metastasis 40%
• Lobectomy 40%
• Thyroid Patients 40%
• Survival Rate 20%
• Cause-specific Survival 20%
• Long-term Clinical Outcome 20%
• Total Thyroidectomy 20%
• Radioactive Iodine Ablation 20%
• Distant Disease-free Survival 20%
• Remnant Thyroid 20%
• After Surgery 10%
• Tumor 10%
• Multivariate Analysis 10%
• Clinical Outcomes 10%
• Risk Factors 10%
• Tumor Size 10%
• Potential Risk Factors 10%
• Univariate Analysis 10%
• Primary Tumor Size 10%
• Thyroidectomy 10%
• Four Factors 10%
• Disease-related 10%
• Curative Intent 10%
• Tumor Diameter 10%
• Ablation Therapy 10%
• Lymph Node Recurrence 10%
• Regional Lymph Node Recurrence 10%

Medicine and Dentistry

• Subtotal Thyroidectomy 100%
• Papillary Thyroid Cancer 100%
• Survival Rate 70%
• Recurrence Free Survival 60%
• Lymph Node Metastasis 40%
• Lobectomy 40%
• Thyroidectomy 30%
• Neoplasm 20%
• Recurrent Disease 20%
• Cause Specific Survival 20%
• Thyroid Gland 20%
• Lymph Node 20%
• Radioactive Iodine 20%
• Primary Tumor 10%
• Univariate Analysis 10%
• Tumor 10%
• Ablation Therapy 10%
• Diseases 10%
• Multivariate Analysis 10%
• Median Follow Up 10%

Nursing and Health Professions

• Thyroid Papillary Carcinoma 100%
• Subtotal Thyroidectomy 100%
• Survival Rate 70%
• Recurrence Free Survival 60%
• Lobectomy 40%
• Lymph Node Metastasis 40%
• Clinical Outcome 30%
• Thyroidectomy 30%
• Recurrent Disease 20%
• Cause Specific Survival 20%
• Tumor Volume 20%
• Radioactive Iodine 20%
• Univariate Analysis 10%
• Neoplasm 10%
• Primary Tumor 10%
• Ablation Therapy 10%
• Diseases 10%
• Multivariate Analysis 10%